Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/2/26 16:30 | 9/30/26 | NAMS | Health | Drug | Pharmaceutical Preparations | Kastelein Johannes Jacob Pieter | DO | Chief Sc | 2 | S.d | -4,621 | 26.37 | 0 | -175 | 123 | I | ||||||||||||||||
9/9/26 16:30 | 9/4/26 | NAMS | Health | Drug | Pharmaceutical Preparations | Smither John W | D | 1 | S | -41 | 25.32 | 0 | -2 | 9 | D | |||||||||||||||||
7/22/26 16:05 | 7/20/26 | NAMS | Health | Drug | Pharmaceutical Preparations | Kooij Louise Frederika | O | Chief Ac | 1 | S.d | -3,186 | 30.34 | 0 | -105 | 24 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |